U-Blot® Research Grade ticalicibartCat. No. WA3652Request quote
Size: 50ug/100ug
Overview
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade ticalicibartCat. No. WA3652U-Blot® Research Grade TibulizumabCat. No. WA3651Request quote
Size: 50ug/100ug
U-Blot® Research Grade TheralizumabCat. No. WA3650Request quote
Size: 50ug/100ug
U-Blot® Research Grade TezepelumabCat. No. WA3649Request quote
Size: 50ug/100ug
U-Blot® Research Grade TesnatilimabCat. No. WA3648Request quote
Size: 50ug/100ug
U-Blot® Research Grade TesidolumabCat. No. WA3647Request quote
Size: 50ug/100ug
U-Blot® Research Grade TeropavimabCat. No. WA3646Request quote
Size: 50ug/100ug
U-Blot® Research Grade TeriparatideCat. No. WA3645Request quote
Size: 50ug/100ug
U-Blot® Research Grade tepsababartCat. No. WA3644Request quote
Size: 50ug/100ug
U-Blot® Research Grade TeprotumumabCat. No. WA3643Request quote
Size: 50ug/100ug
U-Blot® Research Grade TepoditamabCat. No. WA3642Request quote
Size: 50ug/100ug
U-Blot® Research Grade TeplizumabCat. No. WA3641Request quote
Size: 50ug/100ug
REQUEST A QUOTE
EMAILinfo@mail.ucallm.com
PHONE+(1)-866-986-9598
ONLINE FORMOnline Quote Submission
X+(1)-866-986-9598